Norgine
ExitedSpecialty pharmaceutical company
Norgine is tracked in the Tech.eu funding database. Based in Amsterdam, Netherlands; active in Healthtech. Acquired by Goldman Sachs in 2022. Data as of Nov 2026.
Amsterdam, Netherlandsnorgine.com ↗
Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—
Funding rounds
0 roundsNo funding rounds recorded.
Exit
Type
acquisition
Date
Jun 2022
Value
€1.8B
Acquiror
Goldman Sachs (United States of America)
Related news
- Goldman Sachs’ PE arm to acquire majority stake in Amsterdam-based Norgine, reportedly for €1.8Bsiliconcanals.com · 2022-06
Similar companies
same sector, similar size- Sencilia—Netherlands · Healthtech
- Syntilio—Netherlands · Healthtech
- Sensible Healthcare Systems—Netherlands · Healthtech
- Everyday Health—Netherlands · Healthtech
- EarlyDoc—Netherlands · Healthtech
- Xinvento—Netherlands · Healthtech
Global coverage: FundingData